Summary
Introduction
The renin-angiotensin-aldosterone system has been regarded as a defence mechanism to maintain blood pressure in normal man only after Correspondence: Dr G. A. MacGregor, Department of Medicine, Charing Cross Hospital Medical School, London W6 8RF. volume depletion (e.g. blood loss) or sodium depletion or restriction (Haber, 1976) . With the recent development of a specific oral inhibitor of angiotensin converting enzyme (captopril, SQ 14 225) long-term inhibition of the formation of angiotensin I1 is now possible (Ondetti, Rubin & Cushman, 1977) . In this study we have looked at the effect of captopril given for 5 days on blood pressure, aldosterone and sodium balance in normotensive volunteer subjects on three different sodium intakes: low (10 mmol/day), normal (120 mmol/day), high (350 mmol/day). The results suggest that the renin-angiotensinaldosterone system, like the sympathetic nervous sytem, is not only a defence mechanism but a normal mechanism for maintaining blood pressure. This may help to explain some of the recent controversy over the importance of the renin-angiotensin system in the maintenance or causation of blood pressure in essential hypertension (Case, Wallace, Keim, Weber, Drayer, White, Sealey & Laragh, 1976) .
Methods
Normotensive, healthy, male subjects whose diastolic pressure was less than 80 mmHg .after a 2 month observation period were included in the study. All subjects gave their informed consent. Mean age of subjects was 22 years (range 21-26 years). The subjects were studied on three sodium balances, on each balance for 3 weeks, with a gap between each balance period when they ate their normal diet. The low sodium intake was 10 mmol/day, the normal sodium intake was 120 mmol/day and the high sodium intake was 350 mmol/day. The high sodium diet was achieved by supplementing the diet with slow sodium (CIBA). The potassium intake was kept constant at 115 mmol/day for all three diets. All food and drink apart from water was provided by the metabolic ward kitchen. During the 3 weeks of each diet continuous 24 h urine collections were made. The normotensive subjects were allowed to go about their normal activities throughout the study and were not admitted to hospital. They were discouraged from vigorous exercise. Captopril was started on day 8 of the balance, measurements being made 2 h after the first dose of 25 mg. The subjects were allowed to pursue their usual activities during this 2 h period. The dose of captopril was 25 mg three times on day 1, increasing to three doses of 50 mg on day 2 and 100 mg thrice daily for the next 2 days and one dose of 100 mg on the morning of day 5. Daily measurements of blood pressure and 24 h urinary sodium were made. All blood pressures were measured by nurses using semi-automatic ultrasound sphygmomanometers (Arteriosonde 12 17) (George, Lewis & Petrie, 1975) . The mean value of five readings at 1-2 min intervals, supine, sitting and standing, were taken as the blood pressure in that position. Blood pressure measurements were made at the same time of day between 10.00 and 12.00 hours in the same room, by the same nurse, on the same arm. Pulse rate was measured on a Cambridge 3048 pulse monitor with E C G display and recording. Urinary aldosterone was measured 2-4 days before the start of captopril, during the 5 days of captopril and for 4 days after captopril was stopped. Plasma angiotensin 11, plasma renin activity and plasma aldosterone, blood urea, electolytes and plasma creatinine were measured on days 5 and 8 of the balances before captopril, 2 h after the first dose of captopril and on days 4 and 5 during treatment with captopril. All blood was taken without stasis after sitting upright for 5-10 min between 10.00 and 12.00 hours. Plasma renin activity, plasma aldosterone and plasma angiotensin I1 were measured by radioimmunoassay (Dusterdieck & McElwee 1971; James & Wilson, 1976; Roulston & MacGregor, 1978) . Statistical analysis was done using Student's t-test (for hormone measurements log values were used) or, for correlations, the method of least squares. Mean blood pressures were calculated as diastolic pressure + (f x pulse pressure). Results are reported as the mean & SEM.
Results

Normal sodium intake (120 mmollday)
Eight normal subjects were studied on a sodium intake of 120 mmol/day. Captopril caused a significant fall in blood pressure within 2 h of the first dose and this was greater by day 5 (Table 1 ). The percentage fall in mean supine blood pressure with captopril by day 5 was 16.5%. Blood pressure returned to similar levels to the pre-captopril values in the 7 days after stopping captopril. Plasma angiotensin I1 and plasma aldosterone fell with captopril and plasma renin activity rose with captopril ( Table 1) . Mean 24 h urinary sodium excretion 4 days before captopril was 107 +_ 4.3 mmol, and during the 5 days of captopril was 135 2 10.0 mmol. Net loss of sodium during the 5 days of captopril was 142 mmol. All normal subjects lost weight and by day 5 of captopril the mean weight loss was 1.15 kg.
Urinary aldosterone excretion fell during captopril. Mean urinary aldosterone in the 4 days before captopril was 50 C 2-5 nmo1/24 h and during the 5 days of captopril was 36.5 k 3.6 nmo1/24 h.
High sodium intake (350 mmollday)
Seven normal subjects were studied. By day 8 of the high sodium diet in the seven normal subjects, mean 24 h urinary sodium excretion was 334 & 21 mmol. There was no significant change in weight with the high sodium diet. Plasma angiotensin 11, renin activity and aldosterone had fallen ( Table 1) . Captopril caused a significant fall in blood pressure ( Table 1) . The fall was less than on the normal sodium diet but the difference was not significant. The percentage fall in mean supine blood pressure was 11.0%. With captopril, plasma angiotensin I1 and plasma aldosterone fell; plasma renin activity rose (Table 1) . There was no detectable change in sodium balance with captopril. Mean urinary sodium excretion in the 4 days before captopril was 324 t 5.9 mmol and during captopril was 323 k 7.8 mmol. There was no significant change in mean weight with captopril (71.55-71.40 kg). Mean urinary aldosterone in the 4 days before captopril was 18.7 ? 28 nmoV24 h, and during the 5 days of captopril was 16.3 & 1.1 nmo1/24 h.
Low sodium intake (10 mmollday)
Five normal subjects were studied. By day 8 of the low sodium diet the five normal subjects had lost 150.6 mmol of sodium and 1.5 k 0.5 kg. The mean 24 h urinary sodium was 8.6
2.0 mmol. Plasma angiotensin TI. renin and aldosterone had risen ( Table 1) . Blood pressure fell with captopril (Table 1) . The fall in blood pressure was significantly greater than the fall on the high sodium diet ( P < 0.005). The percentage Plasma aldosterone, although showing large falls with captopril, did not fall to the same level on the different diets (Table 1) . Considering all 20 normal subjects who were studied with captopril irrespective of diet, there was a significant correlation between initial log(p1asma renin activity) and the fall in blood pressure (r = 0.71, P < 0.001). There was also a significant correlation between the initial log (angiotensin 11) and the fall in blood pressure ( r = 0.71, P < O.OOl), and a significant correlation between the fall in log(angiotensin 11) and the fall in blood pressure ( r = 0-63, P < 0.001). There was also a significant correlation between the initial plasma renin activity, angiotensin I1 and the fall in angiotensin I1 against the fall in aldosterone that occurred with captopril by day 5 (r = 0.66, r = 0.82, r = 0.78 respectively. P < 0.001). These correlations are not strictly statistically justified as five of the same normal subjects were studied on the three different diets and the diets were not achieved by chance. Nevertheless, they indicate the close relationship between the fall in blood pressure and the initial levels of plasma renin activity, angiotensin I1 and the fall in plasma angiotensin 11. 
Discussion
Captopril in normotensive subjects caused a significant fall in blood pressure on a high, normal or low sodium diet. The fall was greatest on the low sodium diet and was least on the high sodium diet. There is controversy about how captopril might lower blood pressure.
Captopril is known to be a potent inhibitor of angiotensin converting enzyme. Inhibition of this enzyme leads to a fall in circulating angiotensin I1 (Atkinson, Brown, Fraser, Leckie, Lever, Morton & Robertson, 1979; Fagard, Amery, Lijnen & Reybrouck, 1979) . As this enzyme is also partly responsible for the breakdown of bradykinin, there could be an accumulation of bradykinin, a potential vasodilator. Recent work has not confirmed an increase in bradykinin with captopril (Mathews, McGrath & Johnston, 1979 ). Significant correlations have been shown between the fall in angiotensin I1 and the blood pressure fall with captopril in patients with hypertension (Fagard, et al. 1979 ) and saltdepleted dogs (Morton, Tree, Casals-Stenzel, 1980) . Angiotensin I1 has other actions besides those of direct vasoconstriction of arterioles and these may also contribute to the fall in blood pressure with captopril. The fall in aldosterone that occurs within 2 h of the first dose of captopril may also have a blood pressurelowering effect.
Our results showing a close relationship in these normal subjects between the fall in blood pressure with captopril and the initial plasma renin activity, the initial plasma angiotensin I1 and the fall in angiotensin I1 with captopril suggest that part of the mechanism whereby captopril lowers blood pressure is through the reduction in angiotensin I1 that occurs. It might seem surprising that captopril did not have a greater effect on blood pressure on the low sodium diet compared with the high sodium diet. This could be explained by the increased sensitivity of vascular receptors to angiotensin I1 in salt-loaded normal subjects compared with sodium-restricted normal subjects (Oelkers, Brown, Fraser, Lever, Morton & Robertson, 1974) . If part of the mechanism whereby captopril lowers blood pressure is through the fall in angiotensin I1 our results show that the reninangiotensin system is a normal mechanism for maintaining blood pressure in normotensive subjects rather than just a defence mechanism to maintain blood pressure after volume depletion (Haber, 1976) .
The fall in plasma aldosterone that occurred with captopril on all three diets indicates that angiotensin I1 is an important mechanism in maintaining aldosterone secretion, irrespective of sodium intake in normotensive man. However, the plasma aldosterone achieved during captopril was lowest on the high sodium diet and highest on the low sodium diet, illustrating that other factors besides the renin-angiotensin system are also involved in the changes of aldosterone secretion with different sodium intakes.
Captopril caused an increase in sodium excretion on the normal diet and on the low sodium diet but no change on the high sodium diet. This may be due to the fall in angiotensin I1
and/or the fall in aldosterone, and these results provide circumstantial evidence that the reninangiotensin-aldosterone system may be a factor in the control of sodium balance on a low and normal sodium intake but not on a high sodium intake.
The fact that all drugs that block or inhibit the renin-angiotensin-aldosterone system appear to cause the same percentage change in blood pressure for a given plasma renin activity in both normotensive subjects and patients with essential hypertension (MacGregor, Markandu & Roulston, 1979) does suggest that this system plays no greater role in essential hypertension in the maintenance of blood pressure than in normal subjects for a given value of plasma renin activity. Our results with captopril, suggesting that the renin-angiotensin-aldosterone system is a normal mechanism (analogous to the sympathetic nervous system) for maintaining blood pressure in normotensive subjects on a normal sodium intake, necessarily implies that in essential hypertension the renin-angiotensin system is also a normal mechanism for maintaining the blood pressure, but is not the cause of the high blood pressure. The renin-angiotensin system, therefore, can only be the direct cause of high blood pressure if the level of angiotensin I1 is inappropriately high for the sodium balance or if there is an increase in sensitivity to the various actions of angiotensin 11, as compared with normotensive subjects.
